FROM THE TEAM
Cubic Health Launches New Website
Cubic Health is pleased to announce the launch of our new website on February 11 which includes the following features:
An updated, clearly defined Vision and Mission for the future of the company following meetings with our Management Team at the end of 2007
Detailed descriptions of our latest products and services
NEW: An online Request For Quote submission form for a number of our Cubic Health products and services
NEW: A section for Frequently Asked Questions (FAQ) and a separate page where visitors can Ask Us A Question
NEW: A Cubic Health Clients section highlighting some of the clients we are pleased to have completed work for
We hope you find the site informative, functional, and easy to navigate, and welcome any feedback from our audience.
To pass along any comments on Cubic Health Monthly, or to see back issues of our publication, please visit our website at http://www.cubichealth.ca
Sincerely,
Chris von Heymann
Senior Vice President, Consulting Services
| FOR THE PLAN SPONSOR |
PPIs: A Clear Case For A Managed Formulary
Conditions like heartburn, dyspepsia and stomach ulcers are largely managed by drugs from the proton pump inhibitor (PPI) class. By inhibiting acid production in the stomach, these PPIs reduce the acid content that cause the burning symptoms associated with these stomach conditions. As a result of the ubiquitous nature of stomach problems brought about by poor diet, high caffeine intake, use of certain medications (e.g. anti-inflammatories) and abdominal obesity, the demand for PPI therapy has been steadily growing since they became available in the mid 1990's. In a recent analysis of this class of medications, the estimated total number of prescriptions for PPIs dispensed by Canadian retail pharmacies increased by 15% from 10.8 million prescriptions in 2003 to 12.4 million in 2004.1 PPIs routinely show up as one of highest cost medication categories in both publicly and privately funded drug plans.
Click here to read more...
|
|
|
 |
January/February 2008
Issue No. 27 |
 |
QUICK FACTS
|
38%: Percentage of plan members in Canada still covered by a reimbursement-based
private drug plan
39%: Percentage of private drug plans with a generic substitution policy
18%: Percentage of plan members with a tiered plan design as part of their private drug plan
6.5%: Percentage of private drug plans using a customized formulary
|
| Read more... |
|
|
|
 |
|
